StockWatch
·
Pharmaceuticals
Insider Trading27 Jun 2026, 02:00 pm

Amanta Healthcare Closes Trading Window for Insiders

AI Summary

Amanta Healthcare Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut for insiders, connected persons, designated persons, and their immediate relatives from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is standard practice to prevent potential insider trading during sensitive financial reporting periods.

Key Highlights

  • Trading window closed for insiders from July 1, 2026.
  • Closure is in line with SEBI (Prohibition of Insider Trading) Regulations.
  • Window reopens 48 hours after Q1 FY27 unaudited results declaration.
  • Aims to prevent insider trading during financial reporting.